Use of tocilizumab for treatment of COVID-19 from off-label to extended indication-Reference-Cited by-同舟云学术

Use of tocilizumab for treatment of COVID-19 from off-label to extended indication

Published:2022-12-31 Issue:03 Volume:68 Page:579-580
ISSN:1857-8969
Container-title:Macedonian Pharmaceutical Bulletin
language:en
Short-container-title:Maced. Pharm. Bull.

Author:

Velevska Iskra¹,Aleksov Jovana¹,Mihajloska Evgenija¹,Dimkovski Aleksandar¹,Panovska-Stavridis Irina²,Stevanovic Milena³,Grozdanova Aleksandra¹

Affiliation:

1. Faculty of Pharmacy, University “Ss Cyril and Methodius”, Mother Theresa 47, 1000 Skopje, Republic of N. Macedonia

2. University Clinic of Hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Mother Tereza 47, 1000 Skopje, R.N. Macedonia

3. University Clinic of Infection Diseases and Febrile Conditions, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Mother Tereza 47, 1000 Skopje, R.N. Macedonia

Publisher

Macedonian Pharmaceutical Association

Subject

General Medicine

Link

https://bulletin.mfd.org.mk/volumes/Volume%2068_3/68_3_277.pdf

Reference5 articles.

1. EMA, 2021. European Medicines Agency. EMA recommends approval for use of RoActemra in adults with severe COVID-19. Available at: https://www.ema.europa.eu/en/news/ema-recommends-approval-use-roactemra-adults-severe-covid-19 (Last accessed: May 20, 2020)

2. FDA, 2021. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Drug for Treatment of COVID-19. Available at: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-drug-treatment-covid-19 (Last accessed: May 20, 2022)

3. Halimi, V., Daci, A., Stojanovska, S., Panovska-Stavridis, I., Stevanovic, M., Filipce, V., & Grozdanova, A., 2020. Current regulatory approaches for accessing potential COVID-19 therapies. Journal of pharmaceutical policy and practice 13, 16. https://doi.org/10.1186/s40545-020-00222-6

4. MALMED, 2022. Регистар на лекови. Available at: https://lekovi.zdravstvo.gov.mk/drugsregister/overview (Last accessed: May 20, 2022)

5. Panovska, S.I., Ridova, N., Stojanoska, T., Demiri, I., Stevanovic, M., Stojanovska, S., Ristevska, T., Dimkovski, A., Filipce, V., Dimovski, A., Grozdanova, A., 2021. Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management. PRILOZI, vol.42, no.1, 2021, pp.5-18. https://doi.org/10.2478/prilozi-2021-0001